Delivery Order SPE2DB25D9320-SPE2DB25FWFCG
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, valued at $16,249.95, is scheduled for completion by August 20, 2025, with performance at the contractor's Park Ridge facility. The award carries no set-aside designation, reflecting the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Stelara 90 mg/mL syringes. The award represents a firm fixed-price delivery order with no set-aside designation, utilizing the company's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The product will be delivered to Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for $16,249.95 to supply Stelara 90 mg/mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/ml syringes valued at $16,249.95. The contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- SPE2DB25D9320Indefinite Delivery Contract
- SPE2DB25D9320-SPE2DB25FWFCGDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for STELARA 90 MG/ML syringes. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a specific pharmaceutical procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the company to compete on its merits as a qualified supplier despite its woman-owned small business status. The product will be delivered to Park Ridge, Illinois, where the company maintains its operations. This delivery order is issued under DMS Pharmaceutical Group's significant single-award IDC with the Defense Logistics Agency valued at $499.999 billion and valid through November 2026. The parent IDC enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. STELARA, an injectable biologic medication, represents one of many specialized pharmaceutical products the company supplies through this contract vehicle. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides direct distribution of prescription drugs and medical consumables to Department of Defense healthcare sites across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/19/25 |